Your browser doesn't support javascript.
loading
A Phase Ib Dose-Escalation and Expansion Study of the BCL2 Inhibitor Venetoclax Combined with Tamoxifen in ER and BCL2-Positive Metastatic Breast Cancer.
Lok, Sheau W; Whittle, James R; Vaillant, François; Teh, Charis E; Lo, Louisa L; Policheni, Antonia N; Bergin, Alice R T; Desai, Jayesh; Ftouni, Sarah; Gandolfo, Luke C; Liew, Danny; Liu, He K; Mann, G Bruce; Moodie, Kate; Murugasu, Anand; Pal, Bhupinder; Roberts, Andrew W; Rosenthal, Mark A; Shackleton, Kylie; Silva, Maria João; Siow, Zhen R; Smyth, Gordon K; Taylor, Leanne; Travers, Avraham; Yeo, Belinda; Yeung, Miriam M; Bujak, Andjelija Zivanovic; Dawson, Sarah-Jane; Gray, Daniel H D; Visvader, Jane E; Lindeman, Geoffrey J.
  • Lok SW; The Royal Melbourne Hospital, Melbourne, Victoria, Australia.
  • Whittle JR; The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.
  • Vaillant F; The Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Teh CE; The Royal Melbourne Hospital, Melbourne, Victoria, Australia.
  • Lo LL; The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.
  • Policheni AN; The Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Bergin ART; The University of Melbourne, Melbourne, Victoria, Australia.
  • Desai J; The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.
  • Ftouni S; The University of Melbourne, Melbourne, Victoria, Australia.
  • Gandolfo LC; The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.
  • Liew D; The University of Melbourne, Melbourne, Victoria, Australia.
  • Liu HK; The Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Mann GB; The University of Melbourne, Melbourne, Victoria, Australia.
  • Moodie K; The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.
  • Murugasu A; The University of Melbourne, Melbourne, Victoria, Australia.
  • Pal B; The Royal Melbourne Hospital, Melbourne, Victoria, Australia.
  • Roberts AW; The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.
  • Rosenthal MA; The Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Shackleton K; The Royal Melbourne Hospital, Melbourne, Victoria, Australia.
  • Silva MJ; The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.
  • Siow ZR; The Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Smyth GK; The Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Taylor L; The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.
  • Travers A; The University of Melbourne, Melbourne, Victoria, Australia.
  • Yeo B; The University of Melbourne, Melbourne, Victoria, Australia.
  • Yeung MM; School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
  • Bujak AZ; The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.
  • Dawson SJ; The Royal Melbourne Hospital, Melbourne, Victoria, Australia.
  • Gray DHD; The Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Visvader JE; The University of Melbourne, Melbourne, Victoria, Australia.
  • Lindeman GJ; The Royal Women's Hospital, Melbourne, Victoria, Australia.
Cancer Discov ; 9(3): 354-369, 2019 03.
Article en En | MEDLINE | ID: mdl-30518523
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas Proto-Oncogénicas c-bcl-2 / Receptor alfa de Estrógeno Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas Proto-Oncogénicas c-bcl-2 / Receptor alfa de Estrógeno Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Año: 2019 Tipo del documento: Article